Systemic sclerosis-associated interstitial lung disease: Diagnostic approaches and challenges

Bhattacharyya, 2011, Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities, Nat Rev Rheumatol, 8, 42, 10.1038/nrrheum.2011.149 Rubio-Rivas, 2014, Mortality and survival in systemic sclerosis: systematic review and meta-analysis, Semin Arthritis Rheum, 44, 208, 10.1016/j.semarthrit.2014.05.010 Hao, 2017, Early mortality in a multinational systemic sclerosis inception cohort, Arthritis Rheumatol, 69, 1067, 10.1002/art.40027 Tyndall, 2010, Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Ann Rheum Dis, 69, 1809, 10.1136/ard.2009.114264 Denton, 2017, Systemic sclerosis, Lancet, 390, 1685, 10.1016/S0140-6736(17)30933-9 Nihtyanova, 2014, Prediction of pulmonary complications and long-term survival in systemic sclerosis, Arthritis Rheumatol, 66, 1625, 10.1002/art.38390 Schurawitzki, 1990, Interstitial lung disease in progressive systemic sclerosis: high-resolution CT versus radiography, Radiology, 176, 755, 10.1148/radiology.176.3.2389033 Bussone, 2011, Interstitial lung disease in systemic sclerosis, Autoimmun Rev, 10, 248, 10.1016/j.autrev.2010.09.012 Steen, 1994, Severe restrictive lung disease in systemic sclerosis, Arthritis Rheum, 37, 1283, 10.1002/art.1780370903 Sanchez-Cano, 2018, Interstitial lung disease in systemic sclerosis: data from the Spanish scleroderma study group, Rheumatol Int, 38, 363, 10.1007/s00296-017-3916-x Liaskos, 2017, Disease-related autoantibody profile in patients with systemic sclerosis, Autoimmunity, 50, 414, 10.1080/08916934.2017.1357699 Khanna, 2020, Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease, Am J Respir Crit Care Med, 201, 650, 10.1164/rccm.201903-0563CI Steen, 2012, A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis, Arthritis Rheum, 64, 2986, 10.1002/art.34482 Chung, 2020, Increased mortality in Asians with systemic sclerosis in Northern California, ACR Open Rheumatol, 2, 197, 10.1002/acr2.11126 Fairley, 2023, Clinical characteristics and survival of combined pulmonary arterial hypertension and interstitial lung disease in systemic sclerosis, Arthritis Res Ther, 10.1186/s13075-023-03059-x Christmann, 2010, Gastroesophageal reflux incites interstitial lung disease in systemic sclerosis: clinical, radiologic, histopathologic, and treatment evidence, Semin Arthritis Rheum, 40, 241, 10.1016/j.semarthrit.2010.03.002 Elhai, 2019, Performance of candidate serum biomarkers for systemic sclerosis-associated interstitial lung disease, Arthritis Rheumatol, 71, 972, 10.1002/art.40815 Airo, 2011, Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies, J Rheumatol, 38, 1329, 10.3899/jrheum.101144 Hoffmann-Vold, 2017, Cardiopulmonary disease development in anti-RNA polymerase III-positive systemic sclerosis: comparative analyses from an unselected, prospective patient cohort, J Rheumatol, 44, 459, 10.3899/jrheum.160867 Hamaguchi, 2008, The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis, Br J Dermatol, 158, 487, 10.1111/j.1365-2133.2007.08392.x Steen, 2005, Autoantibodies in systemic sclerosis, Semin Arthritis Rheum, 35, 35, 10.1016/j.semarthrit.2005.03.005 Rahaghi, 2023, Expert consensus on the management of systemic sclerosis-associated interstitial lung disease, Respir Res, 24, 10.1186/s12931-022-02292-3 Suliman, 2015, Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease, Arthritis Rheumatol, 67, 3256, 10.1002/art.39405 Mathieson, 1989, Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography, Radiology, 171, 111, 10.1148/radiology.171.1.2928513 Khanna, 2011, Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group, Arthritis Rheum, 63, 3078, 10.1002/art.30467 Moore, 2013, Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease, Rheumatology (Oxford), 52, 155, 10.1093/rheumatology/kes289 Goh, 2008, Interstitial lung disease in systemic sclerosis: a simple staging system, Am J Respir Crit Care Med, 177, 1248, 10.1164/rccm.200706-877OC Launay, 2006, High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis, J Rheumatol, 33, 1789 Hoffmann-Vold, 2015, Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis, Arthritis Rheumatol, 67, 2205, 10.1002/art.39166 Bouros, 2002, Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome, Am J Respir Crit Care Med, 165, 1581, 10.1164/rccm.2106012 Zhou, 2021, HRCT imaging features of systemic sclerosis-associated interstitial lung disease, J Radiol Oncol, 5, 35, 10.29328/journal.jro.1001036 Tashkin, 2006, Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med, 354, 2655, 10.1056/NEJMoa055120 Wells, 2008, High-resolution computed tomography and scleroderma lung disease, Rheumatology (Oxford), 47, v59, 10.1093/rheumatology/ken271 Desai, 2004, CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia, Radiology, 232, 560, 10.1148/radiol.2322031223 Morrisroe, 2020, Incidence, risk factors, and outcomes of cancer in systemic sclerosis, Arthritis Care Res (Hoboken), 72, 1625, 10.1002/acr.24076 Grosse, 2010, CT findings in diseases associated with pulmonary hypertension: a current review, Radiographics, 30, 1753, 10.1148/rg.307105710 Truong, 2012, Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study, Circ Cardiovasc Imaging, 5, 147, 10.1161/CIRCIMAGING.111.968610 Smith, 2023, The emerging association between bronchiectasis and systemic sclerosis: assessing prevalence and potential causality, Intern Med J, 53, 1204, 10.1111/imj.15661 Koo, 2021, Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis, Arthritis Res Ther, 23, 100, 10.1186/s13075-021-02494-y Antoniou, 2016, Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension, Arthritis Rheumatol, 68, 1004, 10.1002/art.39528 Yamakawa, 2018, Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?, BMC Pulm Med, 18, 25, 10.1186/s12890-018-0591-y Hoffmann-Vold, 2020, The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements, Lancet Rheumatol, 2, e71, 10.1016/S2665-9913(19)30144-4 Kim, 2020, Using transitional changes on high-resolution computed tomography to monitor the impact of cyclophosphamide or mycophenolate mofetil on systemic sclerosis-related interstitial lung disease, Arthritis Rheumatol, 72, 316, 10.1002/art.41085 Goldin, 2018, Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II, Ann Am Thorac Soc, 15, 1286, 10.1513/AnnalsATS.201802-079OC Khanna, 2022, Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography, J Scleroderma Relat Disord, 7, 168, 10.1177/23971983211064463 2022 Frauenfelder, 2014, Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study, Ann Rheum Dis, 73, 2069, 10.1136/annrheumdis-2014-205637 Mettler, 2008, Effective doses in radiology and diagnostic nuclear medicine: a catalog, Radiology, 248, 254, 10.1148/radiol.2481071451 Larke, 2011, Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial, Am J Roentgenol, 197, 1165, 10.2214/AJR.11.6533 2010 Katsura, 2017, Effects of pure and hybrid iterative reconstruction algorithms on high-resolution computed tomography in the evaluation of interstitial lung disease, Eur J Radiol, 93, 243, 10.1016/j.ejrad.2017.06.003 Gould, 2014, Clinical practice. Lung-cancer screening with low-dose computed tomography, N Engl J Med, 371, 1813, 10.1056/NEJMcp1404071 Paks, 2018, Ultralow dose CT for follow-up of solid pulmonary nodules: a pilot single-center study using Bland–Altman analysis, Medicine (Baltimore), 97, e12019, 10.1097/MD.0000000000012019 Pinal-Fernandez, 2015, Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome, Clin Exp Rheumatol, 33, S136 Tardella, 2018, Ultrasound B-lines in the evaluation of interstitial lung disease in patients with systemic sclerosis: cut-off point definition for the presence of significant pulmonary fibrosis, Medicine (Baltimore), 97, e0566, 10.1097/MD.0000000000010566 Lavelle, 2017, Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT, Diagn Interv Radiol, 23, 106, 10.5152/dir.2016.15331 Mirsadraee, 2016, T1 characteristics of interstitial pulmonary fibrosis on 3T MRI-a predictor of early interstitial change?, Quant Imaging Med Surg, 6, 42 Bentick, 2022, Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: a systematic literature review, Semin Arthritis Rheum, 57, 152107, 10.1016/j.semarthrit.2022.152107 Moore, 2015, Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease, Clin Exp Rheumatol, 33, S111 Hoffmann-Vold, 2019, Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort, Am J Respir Crit Care Med, 200, 1258, 10.1164/rccm.201903-0486OC Volkmann, 2019, Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts, Ann Rheum Dis, 78, 122, 10.1136/annrheumdis-2018-213708 Kafaja, 2018, Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung Studies (SLS-I and SLS-II), Am J Respir Crit Care Med, 197, 644, 10.1164/rccm.201709-1845OC Hoffmann-Vold, 2021, Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database, Ann Rheum Dis, 80, 219, 10.1136/annrheumdis-2020-217455 Morrisroe, 2017, Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension, Arthritis Res Ther, 19, 122, 10.1186/s13075-017-1341-x Humbert, 2012, Early detection and management of pulmonary arterial hypertension, Eur Respir Rev, 21, 306, 10.1183/09059180.00005112 Humbert, 2023, 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension, Eur Respir J, 61, 2200879, 10.1183/13993003.00879-2022 Humbert, 2011, Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival, Arthritis Rheum, 63, 3522, 10.1002/art.30541 Chausow, 1984, Reversible hypercapnic respiratory insufficiency in scleroderma caused by respiratory muscle weakness, Am Rev Respir Dis, 130, 142 Vandecasteele, 2016, Six-minute walk test in systemic sclerosis: a systematic review and meta-analysis, Int J Cardiol, 212, 265, 10.1016/j.ijcard.2016.03.084 Savarese, 2012, Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials, J Am Coll Cardiol, 60, 1192, 10.1016/j.jacc.2012.01.083 Tomassetti, 2021, Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?, Ther Adv Musculoskelet Dis, 13, 10.1177/1759720X211059605 Wells, 1994, Fibrosing alveolitis in systemic sclerosis. Bronchoalveolar lavage findings in relation to computed tomographic appearance, Am J Respir Crit Care Med, 150, 462, 10.1164/ajrccm.150.2.8049830 Behr, 1996, Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung, Am J Respir Crit Care Med, 154, 400, 10.1164/ajrccm.154.2.8756813 Orlandi, 2022, The role of bronchoalveolar lavage in systemic sclerosis interstitial lung disease: a systematic literature review, Pharmaceuticals (Basel), 15, 10.3390/ph15121584 Flaherty, 2004, Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?, Am J Respir Crit Care Med, 170, 904, 10.1164/rccm.200402-147OC Walsh, 2016, Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study, Lancet Respir Med, 4, 557, 10.1016/S2213-2600(16)30033-9 Furini, 2019, The role of the multidisciplinary evaluation of interstitial lung diseases: systematic literature review of the current evidence and future perspectives, Front Med (Lausanne), 6, 246, 10.3389/fmed.2019.00246 Jo, 2016, Clinical impact of the interstitial lung disease multidisciplinary service, Respirology, 21, 1438, 10.1111/resp.12850 Castelino, 2011, The impact of rheumatological evaluation in the management of patients with interstitial lung disease, Rheumatology (Oxford), 50, 489, 10.1093/rheumatology/keq233 Distler, 2020, Predictors of progression in systemic sclerosis patients with interstitial lung disease, Eur Respir J, 55, 10.1183/13993003.02026-2019 Flaherty, 2019, Nintedanib in progressive fibrosing interstitial lung diseases, N Engl J Med, 381, 1718, 10.1056/NEJMoa1908681 Raghu, 2022, Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline, Am J Respir Crit Care Med, 205, e18, 10.1164/rccm.202202-0399ST Goh, 2017, Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis, Arthritis Rheumatol, 69, 1670, 10.1002/art.40130 Khanna, 2015, Connective tissue disease-associated interstitial lung diseases (CTD-ILD) – report from OMERACT CTD-ILD working group, J Rheumatol, 42, 2168, 10.3899/jrheum.141182 Volkmann, 2022, Early radiographic progression of scleroderma: lung disease predicts long-term mortality, Chest, 161, 1310, 10.1016/j.chest.2021.11.033 Wu, 2019, Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort, Ann Rheum Dis, 78, 648, 10.1136/annrheumdis-2018-213455 Wangkaew, 2016, Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients, Quant Imaging Med Surg, 6, 381, 10.21037/qims.2016.08.08 Boonstra, 2020, Association of anti-topoisomerase I antibodies of the IgM isotype with disease progression in anti-topoisomerase I-positive systemic sclerosis, Arthritis Rheumatol, 72, 1897, 10.1002/art.41403 Volkmann, 2022, Association of symptoms of gastroesophageal reflux, esophageal dilation and progression of systemic sclerosis-related interstitial lung disease, Arthritis Care Res (Hoboken) Zhang, 2013, Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis, J Rheumatol, 40, 850, 10.3899/jrheum.120705 Wu, 2018, Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model, Ann Rheum Dis, 77, 1326, 10.1136/annrheumdis-2018-213201 Fields, 2022, Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses, Thorax Ishikawa, 2012, Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases, Respir Investig, 50, 3, 10.1016/j.resinv.2012.02.001 Tanaka, 2014, IL-6 in inflammation, immunity, and disease, Cold Spring Harb Perspect Biol, 6, 10.1101/cshperspect.a016295 Baldus, 2004, MUC1 and the MUCs: a family of human mucins with impact in cancer biology, Crit Rev Clin Lab Sci, 41, 189, 10.1080/10408360490452040 Abdel-Magied, 2016, Serum interleukin-6 in systemic sclerosis and its correlation with disease parameters and cardiopulmonary involvement, Sarcoidosis Vasc Diffuse Lung Dis, 33, 321 Tiev, 2011, Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis, Eur Respir J, 38, 1355, 10.1183/09031936.00004711 Hoffmann-Vold, 2016, High level of chemokine CCL18 is associated with pulmonary function deterioration, lung fibrosis progression, and reduced survival in systemic sclerosis, Chest, 150, 299, 10.1016/j.chest.2016.03.004 Valerio Marzano, 1998, Elevated circulating CA 15.3 levels in a subset of systemic sclerosis with severe lung involvement, Arch Dermatol, 134, 645, 10.1001/archderm.134.5.645 Wu, 2017, CCL2 in the circulation predicts long-term progression of interstitial lung disease in patients with early systemic sclerosis: data from two independent cohorts, Arthritis Rheumatol, 69, 1871, 10.1002/art.40171 Hoffmann-Vold, 2016, High level of chemokine CCL2 is associated with lung fibrosis progression and reduced survival in two independent systemic sclerosis cohorts [abstract], Arthritis Rheumatol, 68 Yokoyama, 2006, Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis, Respirology, 11, 164, 10.1111/j.1440-1843.2006.00834.x Celeste, 2013, Carbohydrate antigen 15.3 as a serum biomarker of interstitial lung disease in systemic sclerosis patients, Eur J Intern Med, 24, 671, 10.1016/j.ejim.2013.04.004 Kumanovics, 2008, Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis, Clin Exp Rheumatol, 26, 414 Elhaj, 2013, Can serum surfactant protein D or CC-chemokine ligand 18 predict outcome of interstitial lung disease in patients with early systemic sclerosis?, J Rheumatol, 40, 1114, 10.3899/jrheum.120997 De Luca, 2015, Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk, Rheumatology (Oxford), 54, 1991, 10.1093/rheumatology/kev204 Salazar, 2018, KL-6 but not CCL-18 is a predictor of early progression in systemic sclerosis-related interstitial lung disease, J Rheumatol, 45, 1153, 10.3899/jrheum.170518 Kuwana, 2016, Elevated serum krebs von den lungen-6 in early disease predicts subsequent deterioration of pulmonary function in patients with systemic sclerosis and interstitial lung disease, J Rheumatol, 43, 1825, 10.3899/jrheum.160339 Yanaba, 2004, Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis, J Rheumatol, 31, 1112 Hant, 2009, Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma, J Rheumatol, 36, 773, 10.3899/jrheum.080633 Benyamine, 2018, Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease, Rheumatol Int, 38, 813, 10.1007/s00296-018-3987-3 De Lauretis, 2013, Serum interleukin 6 is predictive of early functional decline and mortality in interstitial lung disease associated with systemic sclerosis, J Rheumatol, 40, 435, 10.3899/jrheum.120725 Jee, 2023, A composite serum biomarker index for the diagnosis of systemic sclerosis interstitial lung disease: a multicentre, observational, cohort study, Arthritis Rheumatol, 10.1002/art.42491 Hoffmann-Vold, 2020, Circulating biomarkers of systemic sclerosis – interstitial lung disease, J Scleroderma Relat Disord, 5, 41, 10.1177/2397198319894851 González García, 2022, Left ventricular diastolic dysfunction in systemic sclerosis: clinical, immunological and survival differences in the Spanish RESCLE registry, Semin Arthritis Rheum, 55, 152033, 10.1016/j.semarthrit.2022.152033 Mohri, 2022, High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis, Sci Rep, 12, 2423, 10.1038/s41598-022-06400-7 Tennoe, 2018, Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis, J Am Coll Cardiol, 72, 1804, 10.1016/j.jacc.2018.07.068 Tashkin, 2017, Improved cough and cough-specific quality of life in patients treated for scleroderma-related interstitial lung disease: results of Scleroderma Lung Study II, Chest, 151, 813, 10.1016/j.chest.2016.11.052